SCHEMBL30439166

SCHEMBL30439166

CCC1CN(C(=O)OC(C)(C)C)CCCN1S(=O)(=O)c1cc2ccccc2c(OC)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MMP1 P03956 3/20 0.47
▸ MMP9 P14780 3/20 0.47
▸ MMP13 P45452 3/20 0.47
▸ HTR6 P50406 3/20 0.42
▸ MMP3 P08254 1/20 0.41
▸ MMP7 P09237 1/20 0.41
▸ ADAM17 P78536 1/20 0.39
▸ BCHE P06276 2/20 0.39
▸ KAT7 O95251 1/20 0.38
▸ KAT8 Q9H7Z6 1/20 0.38
▸ BRD4 O60885 1/20 0.38
▸ ACKR3 P25106 1/20 0.38
▸ CKS1B P61024 1/20 0.37
▸ SKP1 P63208 1/20 0.37
▸ SKP2 Q13309 1/20 0.37
▸ APLNR P35414 1/20 0.37
▸ TGFBR1 P36897 2/20 0.37
▸ USP30 Q70CQ3 2/20 0.36
▸ GPR119 Q8TDV5 1/20 0.36
▸ PRMT5 O14744 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30439149 0.90 MMP1 (0.45) MMP1MMP9MMP13HTR6MMP3
SCHEMBL24178165 0.83 MMP13 (0.43) MMP1MMP9MMP13HTR6MMP3
SCHEMBL30439175 0.83 MMP13 (0.43) MMP1MMP9MMP13HTR6MMP3
SCHEMBL23795403 0.83 MMP13 (0.43) MMP1MMP9MMP13HTR6MMP3
SCHEMBL30439332 0.79 MMP13 (0.45) MMP1MMP9MMP13HTR6MMP3
SCHEMBL30439444 0.79 MMP13 (0.43) MMP1MMP9MMP13HTR6MMP3
SCHEMBL30438744 0.78 MMP1 (0.38) MMP1MMP9MMP13HTR6
SCHEMBL22089008 0.74 MMP1 (0.53) MMP1MMP9MMP13HTR6MMP3
SCHEMBL568168 0.74 MMP13 (0.49) MMP1MMP9MMP13MMP3MMP7
SCHEMBL568169 0.74 MMP13 (0.49) MMP1MMP9MMP13MMP3MMP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111116555-B Rho kinase inhibitor and preparation method and application thereof 北京盈科瑞创新药物研究有限公司 2023-06-02 — — CN disclosed
Send feedback